Abstract
We demonstrate a versatile phase-change sub-micron contrast agent providing three modes of contrast enhancement: 1) photoacoustic imaging contrast, 2) ultrasound contrast with optical activation, and 3) ultrasound contrast with acoustic activation. This agent, which we name ‘Cy-droplet’, has the following novel features. It comprises a highly volatile perfluorocarbon for easy versatile activation, and a near-infrared optically absorbing dye chosen to absorb light at a wavelength with good tissue penetration. It is manufactured via a ‘microbubble condensation’ method. The phase-transition of Cy-droplets can be optically triggered by pulsed-laser illumination, inducing photoacoustic signal and forming stable gas bubbles that are visible with echo-ultrasound in situ. Alternatively, Cy-droplets can be converted to microbubble contrast agents upon acoustic activation with clinical ultrasound. Potentially all modes offer extravascular contrast enhancement because of the sub-micron initial size. Such versatility of acoustic and optical ‘triggerability’ can potentially improve multi-modality imaging, molecularly targeted imaging and controlled drug release.
Original language | English (US) |
---|---|
Pages (from-to) | 26-36 |
Number of pages | 11 |
Journal | Photoacoustics |
Volume | 6 |
DOIs | |
State | Published - Jun 1 2017 |
Keywords
- Droplet
- Microbubble
- Multispectral optoacoustic tomography (MSOT)
- Optical/acoustic vaporisation
- Phase-change contrast agent
- Photoacoustic
- Ultrasound
ASJC Scopus subject areas
- Atomic and Molecular Physics, and Optics
- Radiology Nuclear Medicine and imaging